Craft

Samjin Pharmaceutical

Stock Price

₩18.2 K

2024-10-29

Market Capitalization

₩227.6 B

2024-10-29

Revenue

₩309.1 B

FY, 2025

Samjin Pharmaceutical Summary

Company Summary

Overview
Samjin Pharmaceutical (삼진제약) is a company that specializes in the drug development area. It is engaged in the production of medications for the treatment of cancer, fibrotic diseases, age-related macular degeneration (AMD), and Alzheimer's disease. The company focuses on formulation research, pharmacology and toxicity evaluation, efficacy testing, chemical synthesis, and licensing of novel therapeutics.
Type
Public
Status
Active
Founded
1968
Website
https://www.samjinpharm.co.kr/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Samjin Pharmaceutical Financials

Summary Financials

Revenue (FY, 2025)
₩309.1B
Gross profit (FY, 2025)
₩144.3B
Net income (FY, 2025)
₩24.2B
Cash (FY, 2025)
₩12.1B
EBIT (FY, 2025)
₩26.2B
Enterprise value
$351.1B

Footer menu